CNTX Latest Press Releases

-- September 9, 2026 --

Context Therapeutics Announces First Patient Dosed in Phase 1 Trial of CT-202 Globe Newswire 7:30 AM

-- August 5, 2026 --

Context Therapeutics Reports Second Quarter 2026 Operating and Pipeline Progress Globe Newswire 4:14 PM

-- July 10, 2026 --

-- July 6, 2026 --

Context Therapeutics Added to Russell 2000 and Russell 3000 Indexes Globe Newswire 4:07 PM

-- June 15, 2026 --

-- June 9, 2026 --